The Food and Drugs Authority (FDA) has approved two more COVID-19 vaccines for importation, distribution, and use in Ghana.

The two new vaccines are Moderna (Spikevax) and Pfizer-BioNtech (Comirnaty), bringing the total number of approved COVID-19 vaccines for use in the country to five.

The others are Sputnik V, Covishield and Covidd-19 Vaccine Jassen.

The FDA, in a statement, said it will continue to use the Emergency Use Authorisation (EUA) pathway, which is the acceptable procedure for all national regulatory authorities globally, in order to ensure timely access to quality and safe medical products including vaccines during this pandemic.

The authority has assured the public that all approved COVID-19 vaccines have been subjected to rigorous safety parameters and, therefore, the public can take them without reservations.